
June 12, 2026
Trump Seeks To Make Medicare Drug Price Negotiations Permanent In Regulation The Trump administration and the Centers for Medicare & Medicaid Services (CMS) have proposed to codify the Biden-era Medicare Drug Price Negotiation Program — a fantastic turn of events that few would have predicted a few years ago despite Trump’s sympathies for drug price reform. They say the move will create a more transparent and sustainable process for lowering drug costs for millions of Medicare beneficiaries. There are a number of small concessions to drug makers as well. I have given President Trump great credit for making a huge impact on drug pricing, more than any other recent president. This is more evidence. Additional articles: https://www.cms.gov/newsroom/press-releases/cms-proposed-rule-locks-lower-prices-fosters-innovation-medicare-drug-price-negotiation-program and https://www.cms.gov/files/document/mdpnp-nprm-fact-sheet.pdf #drugpricing #cms #medicare #partd #medicareadvantage #pdp https://www.fiercehealthcare.com/regulatory/cms-proposes-permanent-framework-medicare-drug-price-negotiations Democrats Search For The Next Obamacare Democrats are seeking to find their next Obamacare to win votes in the midterms. Lawmakers and policymakers are


